Antiglycine receptor antibody related disease: a case series and literature review

Antibodies to glycine receptors (GlyR‐Abs) were first defined in progressive encephalopathy with rigidity and myoclonus (PERM) but were subsequently identified in other clinical presentations. Our aim was to assess the clinical associations of all patients identified with GlyR‐Abs in Queensland, Australia, between April 2014 and May 2017 and to compare these to cases reported in the literature.

[1]  A. Vincent,et al.  Redefining progressive encephalomyelitis with rigidity and myoclonus after the discovery of antibodies to glycine receptors , 2017, Current opinion in neurology.

[2]  C. Geis,et al.  Autoantibodies to Synaptic Receptors and Neuronal Cell Surface Proteins in Autoimmune Diseases of the Central Nervous System. , 2017, Physiological reviews.

[3]  A. Vincent,et al.  Focal status epilepticus and progressive dyskinesia: A novel phenotype for glycine receptor antibody-mediated neurological disease in children. , 2017, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.

[4]  K. Abdel-Aziz,et al.  NORSE ASSOCIATED WITH ANTI-GLYCINE RECEPTOR ANTIBODIES , 2016, Journal of Neurology, Neurosurgery & Psychiatry.

[5]  G. Ambegaonkar,et al.  Glycine receptor antibody-associated epilepsy in a boy aged 4 years , 2016, BMJ Case Reports.

[6]  Y. Blanco,et al.  Clinical and Immunologic Investigations in Patients With Stiff-Person Spectrum Disorder. , 2016, JAMA neurology.

[7]  H. Breitinger,et al.  In Vivo Protection against Strychnine Toxicity in Mice by the Glycine Receptor Agonist Ivermectin , 2014, BioMed research international.

[8]  C. Bien,et al.  Glycine receptor antibodies in a boy with focal epilepsy and episodic behavioral disorder , 2014, Journal of the Neurological Sciences.

[9]  B. Giometto,et al.  Glycine receptor antibodies in 2 cases of new, adult-onset epilepsy , 2014, Neurology: Neuroimmunology & Neuroinflammation.

[10]  A. Vincent,et al.  Glycine receptor antibodies in PERM and related syndromes: characteristics, clinical features and outcomes , 2014, Brain : a journal of neurology.

[11]  A. Vincent,et al.  Investigation of neuronal autoantibodies in two different focal epilepsy syndromes , 2014, Epilepsia.

[12]  A. Vincent,et al.  Glycine receptor and myelin oligodendrocyte glycoprotein antibodies in Turkish patients with neuromyelitis optica , 2013, Journal of the Neurological Sciences.

[13]  P. Santens,et al.  Anti-Glycine Receptor Antibody Mediated Progressive Encephalomyelitis with Rigidity and Myoclonus Associated with Breast Cancer , 2013, Case reports in neurological medicine.

[14]  M. Brodie,et al.  Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy , 2013, Epilepsia.

[15]  B. Orser,et al.  Tranexamic acid concentrations associated with human seizures inhibit glycine receptors. , 2012, The Journal of clinical investigation.

[16]  A. Vincent,et al.  Supranuclear gaze palsy in glycine receptor antibody‐positive progressive encephalomyelitis with rigidity and myoclonus , 2012, Movement disorders : official journal of the Movement Disorder Society.

[17]  R. Howard,et al.  GLYCINE RECEPTOR ANTIBODY MEDIATED PROGRESSIVE ENCEPHALOMYELITIS WITH RIGIDITY AND MYOCLONUS (PERM) PRESENTING WITH RESPIRATORY COMPROMISE IN A 40-YEAR-OLD MALE , 2012, Journal of Neurology, Neurosurgery & Psychiatry.

[18]  C. Becker,et al.  Inhibitory Glycine Receptors: An Update* , 2012, The Journal of Biological Chemistry.

[19]  A. Vincent,et al.  Glycine receptor antibodies are detected in progressive encephalomyelitis with rigidity and myoclonus (PERM) but not in saccadic oscillations , 2012, Journal of Neurology.

[20]  H. Shigeto,et al.  Thymoma-Associated Progressive Encephalomyelitis with Rigidity and Myoclonus Successfully Treated with Thymectomy and Intravenous Immunoglobulin , 2011, European Neurology.

[21]  M. Turner,et al.  Progressive encephalomyelitis with rigidity and myoclonus , 2011, Neurology.

[22]  W. Lu,et al.  Role of Glycine Receptors in Glycine-Induced LTD in Hippocampal CA1 Pyramidal Neurons , 2011, Neuropsychopharmacology.

[23]  A. Vincent,et al.  Antiglycine-receptor encephalomyelitis with rigidity , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[24]  Tian-Le Xu,et al.  Glycine and glycine receptor signaling in hippocampal neurons: Diversity, function and regulation , 2010, Progress in Neurobiology.

[25]  J. White,et al.  Glycinergic Inhibition in the Hippocampus , 2009, Reviews in the neurosciences.

[26]  Michael K. Hutchinson,et al.  PROGRESSIVE ENCEPHALOMYELITIS, RIGIDITY, AND MYOCLONUS: A NOVEL GLYCINE RECEPTOR ANTIBODY , 2008, Neurology.

[27]  T. Gloveli,et al.  Glycinergic tonic inhibition of hippocampal neurons with depolarizing GABAergic transmission elicits histopathological signs of temporal lobe epilepsy , 2008, Journal of cellular and molecular medicine.

[28]  J. Lynch,et al.  Molecular structure and function of the glycine receptor chloride channel. , 2004, Physiological reviews.

[29]  J. Breustedt,et al.  Effects of Taurine and Glycine on Epileptiform Activity Induced by Removal of Mg2+ in Combined Rat Entorhinal Cortex–Hippocampal Slices , 2003, Epilepsia.

[30]  M. Owen,et al.  Compound heterozygosity and nonsense mutations in the α1-subunit of the inhibitory glycine receptor in hyperekplexia , 2001, Human Genetics.